View in EDS HTML Full Text PDF Full Text

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.

Saved in:
Bibliographic Details
Title: Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
Authors: Klein-Scory S; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany., Baraniskin A; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.; Department of Hematology, Oncology and Palliative Care, Evangelisches Krankenhaus Hamm gGmbH, Germany., Schmiegel W; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany., Mika T; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany., Schroers R; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany., Held S; ClinAssess GmbH, Leverkusen, Germany., Heinrich K; Department of Oncology, LMU University Hospital, Munich, Germany., Tougeron D; Department of Hepato-Gastroenterology, Poitiers University Hospital and University of Poitiers, France., Modest DP; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany., Schwaner I; Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany., Eucker J; Department of Hematology, Oncology, and Cancer Immunology (CBF), Charité-Universitaetsmedizin Berlin, Germany., Pihusch R; MVZ Praxis Pihusch, Rosenheim, Germany., Stauch M; Hematology, Oncology/Hemostaseology Kronach, Germany., Kaiser F; VK&K Studien GmbH, Landshut, Germany., Kahl C; Klinikum Magdeburg gGmbH, Department of Hematology, Oncology and Palliative Care Magdeburg, Germany.; Department of Internal Medicine, Clinic III - Hematology, Oncology and Palliative Care, Rostock University Medical Center, Germany., Karthaus M; Department of Hematology, Oncology and Palliative Care, München Klinik Harlaching and Neuperlach, Germany., Müller C; Evang. Kliniken Essen-Mitte, Germany., Burkart C; Schwarzwald-Baar Klinikum Villingen-Schwenningen, Germany., Stintzing S; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Site Berlin Heidelberg, Germany., Heinemann V; Department of Medicine III, LMU Klinikum, Comprehensive Cancer Center Munich, Germany.; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Site Munich Heidelberg, Germany.
Source: Molecular oncology [Mol Oncol] 2025 Feb; Vol. 19 (2), pp. 344-356. Date of Electronic Publication: 2024 Dec 04.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39630848
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klein-Scory+S%22">Klein-Scory S</searchLink>; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Baraniskin+A%22">Baraniskin A</searchLink>; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.; Department of Hematology, Oncology and Palliative Care, Evangelisches Krankenhaus Hamm gGmbH, Germany.<br /><searchLink fieldCode="AU" term="%22Schmiegel+W%22">Schmiegel W</searchLink>; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Mika+T%22">Mika T</searchLink>; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Schroers+R%22">Schroers R</searchLink>; Department of Internal Medicine, Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH, Ruhr University Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Held+S%22">Held S</searchLink>; ClinAssess GmbH, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Heinrich+K%22">Heinrich K</searchLink>; Department of Oncology, LMU University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Tougeron+D%22">Tougeron D</searchLink>; Department of Hepato-Gastroenterology, Poitiers University Hospital and University of Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Modest+DP%22">Modest DP</searchLink>; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schwaner+I%22">Schwaner I</searchLink>; Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Eucker+J%22">Eucker J</searchLink>; Department of Hematology, Oncology, and Cancer Immunology (CBF), Charité-Universitaetsmedizin Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Pihusch+R%22">Pihusch R</searchLink>; MVZ Praxis Pihusch, Rosenheim, Germany.<br /><searchLink fieldCode="AU" term="%22Stauch+M%22">Stauch M</searchLink>; Hematology, Oncology/Hemostaseology Kronach, Germany.<br /><searchLink fieldCode="AU" term="%22Kaiser+F%22">Kaiser F</searchLink>; VK&K Studien GmbH, Landshut, Germany.<br /><searchLink fieldCode="AU" term="%22Kahl+C%22">Kahl C</searchLink>; Klinikum Magdeburg gGmbH, Department of Hematology, Oncology and Palliative Care Magdeburg, Germany.; Department of Internal Medicine, Clinic III - Hematology, Oncology and Palliative Care, Rostock University Medical Center, Germany.<br /><searchLink fieldCode="AU" term="%22Karthaus+M%22">Karthaus M</searchLink>; Department of Hematology, Oncology and Palliative Care, München Klinik Harlaching and Neuperlach, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+C%22">Müller C</searchLink>; Evang. Kliniken Essen-Mitte, Germany.<br /><searchLink fieldCode="AU" term="%22Burkart+C%22">Burkart C</searchLink>; Schwarzwald-Baar Klinikum Villingen-Schwenningen, Germany.<br /><searchLink fieldCode="AU" term="%22Stintzing+S%22">Stintzing S</searchLink>; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Site Berlin Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heinemann+V%22">Heinemann V</searchLink>; Department of Medicine III, LMU Klinikum, Comprehensive Cancer Center Munich, Germany.; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Site Munich Heidelberg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2025 Feb; Vol. 19 (2), pp. 344-356. <i>Date of Electronic Publication: </i>2024 Dec 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39630848
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13778
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 344
    Titles:
      – TitleFull: Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klein-Scory S
      – PersonEntity:
          Name:
            NameFull: Baraniskin A
      – PersonEntity:
          Name:
            NameFull: Schmiegel W
      – PersonEntity:
          Name:
            NameFull: Mika T
      – PersonEntity:
          Name:
            NameFull: Schroers R
      – PersonEntity:
          Name:
            NameFull: Held S
      – PersonEntity:
          Name:
            NameFull: Heinrich K
      – PersonEntity:
          Name:
            NameFull: Tougeron D
      – PersonEntity:
          Name:
            NameFull: Modest DP
      – PersonEntity:
          Name:
            NameFull: Schwaner I
      – PersonEntity:
          Name:
            NameFull: Eucker J
      – PersonEntity:
          Name:
            NameFull: Pihusch R
      – PersonEntity:
          Name:
            NameFull: Stauch M
      – PersonEntity:
          Name:
            NameFull: Kaiser F
      – PersonEntity:
          Name:
            NameFull: Kahl C
      – PersonEntity:
          Name:
            NameFull: Karthaus M
      – PersonEntity:
          Name:
            NameFull: Müller C
      – PersonEntity:
          Name:
            NameFull: Burkart C
      – PersonEntity:
          Name:
            NameFull: Stintzing S
      – PersonEntity:
          Name:
            NameFull: Heinemann V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1